Twist Bioscience Corporation Common Stock (TWST) Financials
Key financial figures for Twist Bioscience Corporation Common Stock (Q3 2026).
Twist Bioscience Corp. reported revenue of $118.4 million for Q3 FY2026, up 23.2% from the same period a year earlier. The company posted a net loss of $35.1 million, or -$0.56 per share. Operating margin came to -30.65%, against -31.36% a year earlier. Free cash flow for the period was -$8.5 million. Across the last 5 reported quarters, quarterly revenue has risen from $96.1 million in Q3 FY2025 to $118.4 million in Q3 FY2026. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Twist Bioscience Corp. are on the SentiSense financials page.
- Revenue
- $118M
- Net Income
- -$35M
- EPS
- $-0.56
- Total Assets
- $672M
- Operating Cash Flow
- $1M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $118M | -$35M | -$0.56 | -30.65% | -$9M |
| Q2 FY2026 | $111M | -$44M | -$0.71 | -34.92% | -$26M |
| Q1 FY2026 | $104M | -$31M | -$0.50 | -31.73% | -$35M |
| Q4 FY2025 | $99M | -$27M | -$0.45 | -30.23% | -$24M |
| Q3 FY2025 | $96M | $20M | $0.33 | -31.36% | -$11M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $377M | -$78M | -$1.30 | -36.18% | -$76M |
| FY2024 | $313M | -$209M | -$3.60 | -70.56% | -$69M |
| FY2023 | $245M | -$205M | -$3.60 | -88.6% | -$170M |
Frequently asked questions
What was Twist Bioscience Corp.'s revenue last quarter?
Twist Bioscience Corp. reported revenue of $118.4 million for Q3 FY2026, up 23.2% from the same period a year earlier.
Is Twist Bioscience Corp. profitable?
Not in its most recent reported period. Twist Bioscience Corp. reported a net loss of $35.1 million for Q3 FY2026, a net margin of -29.61% on revenue.
How has Twist Bioscience Corp.'s margin trended?
Operating margin was -30.65% in Q3 FY2026, compared with -31.36% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Twist Bioscience Corp. generate?
Twist Bioscience Corp. generated free cash flow of -$8.5 million in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Twist Bioscience Corporation Common Stock on SentiSense, with up to forty quarters and twenty fiscal years of history.